Loading organizations...
§ Private Profile · Wilmington, DE, USA
Digital health company developing digital therapeutics and EHR-integrated solutions for healthcare, focused on chronic conditions.
Amalgam Rx is a Wilmington, Delaware-based digital health company that develops and distributes regulated digital therapeutics and clinical decision support tools integrated directly into electronic health record workflows. Operating with a workforce of 51 to 100 employees, the enterprise software provider has scaled its algorithms and applications to support nearly 10 million patients and over 50 million provider decisions across four continents. The company partners with major life sciences organizations and health systems to commercialize its digital solutions, securing strategic collaborations with pharmaceutical entities such as Sanofi and Novo Nordisk. Backed by approximately $27.9 million in total venture funding, including a Series B round led by CVS Health Ventures, the firm has expanded its capabilities through strategic moves like the acquisition of Avhana Health. Amalgam Rx was founded in 2016 by Ryan Sysko and Dr. Suzanne Clough.
Amalgam Rx has raised $37.4M across 2 funding rounds.
Amalgam Rx has raised $37.4M in total across 2 funding rounds.
Amalgam Rx has raised $37.4M across 2 funding rounds. Most recently, it raised $20.0M Debt in August 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 12, 2025 | $20M Debt Financing | Catalio Capital | — | Announced |
| Jan 9, 2023 | $17.4M Series A | Thomas Thestrup Terp | — | Announced |
Amalgam Rx has raised $37.4M in total across 2 funding rounds.
Amalgam Rx's investors include Catalio Capital Management, Thomas Thestrup-Terp.